LIANBIO's ticker is and the CUSIP is 53000N108. A total of 41 filers reported holding LIANBIO in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $85,762,091 | -34.6% | 57,558,451 | 0.0% | 2.86% | -24.7% |
Q2 2023 | $131,233,268 | +16.3% | 57,558,451 | 0.0% | 3.80% | +14.0% |
Q1 2023 | $112,814,563 | +19.5% | 57,558,451 | 0.0% | 3.33% | +25.7% |
Q4 2022 | $94,395,859 | -18.0% | 57,558,451 | 0.0% | 2.65% | -20.7% |
Q3 2022 | $115,116,000 | -5.8% | 57,558,451 | +1.8% | 3.34% | -12.7% |
Q2 2022 | $122,170,000 | -41.5% | 56,560,211 | +0.4% | 3.83% | -8.6% |
Q1 2022 | $208,947,000 | -69.9% | 56,319,960 | -50.0% | 4.18% | -21.8% |
Q4 2021 | $693,862,000 | – | 112,639,920 | – | 5.35% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 2,282,084 | $4,929,000 | 4.16% |
Perceptive Advisors | 56,560,211 | $122,170,000 | 3.83% |
SCHF (GPE), LLC | 937,500 | $2,025,000 | 2.99% |
VR Adviser, LLC | 5,378,341 | $11,617,000 | 2.29% |
TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 3,314,173 | $7,159,000 | 0.52% |
Affinity Asset Advisors, LLC | 450,000 | $972,000 | 0.41% |
Altium Capital Management LP | 315,191 | $681,000 | 0.27% |
RA Capital Management | 4,622,574 | $9,985,000 | 0.27% |
22NW, LP | 141,223 | $305,000 | 0.16% |
Logos Global Management LP | 394,486 | $852,000 | 0.16% |